The new drug R&D in Korea targeted to the synthetic chemical compounds by 35%, the natural crude drug by 22%, the modified new drug by 14% and the bio tech product by 29%, showing more weight shift from the synthetic compounds to the bio, natural crude and modified new drugs.
By therapeutic group, it showed the top with antibiotics, then, the drugs for metabolic and cardiovascular disorders ...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.